Healthcare & Life Sciences

Kapa Biosystems

United States
acquiredacquired
Sign in to unlock
acquired
Stage

About

Kapa Biosystems developed next-generation PCR reagents by using molecular evolution technology to optimize enzymes for DNA amplification, sequencing, and molecular diagnostic applications.

Explore Kapa Biosystems's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing